What was the market valuation of the US cardiac implants market in 2024?

The market valuation of the US cardiac implants market was $11.5 Billion in 2024. Read More

What is the projected market valuation for the US cardiac implants market by 2035?

The projected market valuation for the US cardiac implants market is $24.0 Billion by 2035. Read More

What is the expected CAGR for the US cardiac implants market during the forecast period 2025 - 2035?

The expected CAGR for the US cardiac implants market during the forecast period 2025 - 2035 is 6.92%. Read More

Which key players are leading the US cardiac implants market?

Key players in the US cardiac implants market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and St. Jude Medical. Read More

What are the major segments of the US cardiac implants market?

The major segments of the US cardiac implants market include indications, devices, and end-users. Read More

What was the market size for arrhythmias in the US cardiac implants market in 2024?

The market size for arrhythmias in the US cardiac implants market was $2.3 Billion in 2024. Read More

What is the projected market size for heart failure devices by 2035?

The projected market size for heart failure devices is $6.5 Billion by 2035. Read More

How much is the market for cardiac rhythm management devices expected to grow by 2035?

The market for cardiac rhythm management devices is expected to grow to $8.0 Billion by 2035. Read More

What was the market size for hospitals as an end-user in 2024?

The market size for hospitals as an end-user in 2024 was $5.0 Billion. Read More

What is the projected market size for coronary stents by 2035?

The projected market size for coronary stents is $6.0 Billion by 2035. Read More

US Cardiac Implants Market

ID: MRFR/MED/51271-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

US Cardiac Implants Market Research Report By Device (Coronary Stents, Prosthetic Heart Valve Devices, Others), By Indication (Arrhythmias, Heart Failure, Others) and By End User (Hospitals, Cardiac Care Centers, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Indication (USD Billion)
  1. 4.1.1 Arrhythmias
  2. 4.1.2 Myocardial Ischemia
  3. 4.1.3 Acute Myocardial Infarction
  4. 4.1.4 Heart Failure
  5. 4.1.5 Others
2. 4.2 Chemicals and Materials, BY Device (USD Billion)
  1. 4.2.1 Implantable Loop Recorder
  2. 4.2.2 Cardiac Rhythm Management Devices
  3. 4.2.3 Coronary Stents
  4. 4.2.4 Ventricular Assist Devices
  5. 4.2.5 Others
3. 4.3 Chemicals and Materials, BY End-User (USD Billion)
  1. 4.3.1 Cardiac Care Centers
  2. 4.3.2 Ambulatory Centers
  3. 4.3.3 Hospitals
  4. 4.3.4 Academic Institutes
  5. 4.3.5 Home Care
  6. 4.3.6 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Edwards Lifesciences (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Biotronik (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 LivaNova (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 St. Jude Medical (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Terumo (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Cardiac Science (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY INDICATION
3. 6.3 US MARKET ANALYSIS BY DEVICE
4. 6.4 US MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY INDICATION, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY INDICATION, 2024 TO 2035 (USD Billion)
13. 6.13 CHEMICALS AND MATERIALS, BY DEVICE, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY DEVICE, 2024 TO 2035 (USD Billion)
15. 6.15 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Billion)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY INDICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY DEVICE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Indication (USD Billion, 2025-2035)

Arrhythmias
Myocardial Ischemia
Acute Myocardial Infarction
Heart Failure
Others

Chemicals and Materials By Device (USD Billion, 2025-2035)

Implantable Loop Recorder
Cardiac Rhythm Management Devices
Coronary Stents
Ventricular Assist Devices
Others

Chemicals and Materials By End-User (USD Billion, 2025-2035)

Cardiac Care Centers
Ambulatory Centers
Hospitals
Academic Institutes
Home Care
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”